Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2020

Schedule of Stock-based Compensation

Stock-based compensation, including stock options, warrants and restricted stock, expense is included in the consolidated statement of operations as follows:

	Years Ended December 31,
	2020		2019
Research and development	$	65,433	$	(40,828	)
Sales and marketing		160,480		46,723
General and administrative		1,601,095		3,366,831
Total	$	1,827,008	$	3,372,726

Schedule of Stock-based Compensation, Stock Options, Activity

The following table reflects the stock option activity:

	Number of Shares			Weighted Average Exercise Price			Contractual Life (Years)
Outstanding at December 31, 2018		899,844		$	2.45			5.80
Granted		890,300			3.54
Exercised		-			-			-
Cancellations		(477,190	)		3.08
Forfeitures		(316,309	)		3.08
Outstanding at December 31, 2019		996,645		$	2.92			5.73
Assumed as part of the Merger		61,440			46.95
Granted		896,269			3.06
Exercised		(6,817	)		(2.45	)
Forfeitures		(27,268	)		(2.86	)
Outstanding at December 31, 2020		1,920,269		$	4.40			8.66

Schedule of Stock-based Payment Award, Stock Options, Valuation Assumptions

The Company uses the following inputs when valuing stock-based awards.

	As of December 31,
	2020			2019
Expected life (years)		5.0			5.0
Risk-free interest rate		0.38	%		1.62	%
Expected volatility		89.76	%		73.20	%
Total grant date fair value	$	1.83 to $2.81		$	3.45

Restricted Common Stock [Member]

Schedule of Stock-based Compensation, Stock Options, Activity

The following table reflects the restricted stock activity:

	Number of Shares			Weighted Average Grant Price
Outstanding at December 31, 2019		-		$	0
Granted		1,087,618			5.27
Vested		(15,115	)		(3.17	)
Outstanding at December 31, 2020		1,072,503		$	5.30